The AIDS Support Organisation (TASO) and Medical Access Uganda Limited (MAUL) have committed to maintain a continuous supply of Antiretroviral (ARVs) drugs to over 75,000 clients under the care of TASO. This commitment was part of the resolutions made during a consultative meeting between TASO and MAUL held on Thursday at Imperial Royale Hotel, Kampala.
The meeting was held to share feedback and agree on the way forward to better the partnership between the two organizations, for improved quality service delivery to the beneficiaries. It was attended by selected representatives from all the 11 TASO Service Centres of Excellence (CoE) and the headquarter team and included; Centre Managers, Medical Coordinators, Pharmacy Technicians and Programme Management and Advocacy team. MAUL representatives comprised Head Office Management and Technical team and Field Services Supervisors.
The two partners concurred that continuous supply of life saving ARVs and other commodities is critical in safeguarding the lives of their clients. Re-echoing the voices of the participants, Dr. Rashid Settaala, the Director of Programmes at MAUL said, “In our partnership, we will continue to work around any transitions to ensure a continuous supply of quality commodities to TASO and all the other Implementing Partners we work with.”
Dr. Baker Bakashaba, TASO’s Manager Medical Services, who chaired the meeting, noted that the commitments by the two parties have a direct bearing on the lives of clients and were also an accountability to the development partner, US Centers for Disease Control & Prevention (CDC). CDC funds TASO treatment intervention and MAUL Procurement and Supply Chain Strengthening Project. CDC was acknowledged for this great support to the two partners and the clients who benefit from the services.
Mr. Isaac Mutabaazi, Pharmacist at TASO Headquarters, appreciated MAUL for its responsiveness to issues of concern by their partners. He noted that this meeting has shown the value MAUL attaches to partnership for health and better life. He pledged TASO’s readiness to address areas of improvement noted in the discussions and technical support supervision reports. On their part, MAUL said they value the partnership with TASO and will ensure that there is continuous availability and access to drugs by people living with HIV/AIDS.
Medical Access Uganda Limited (MAUL), a non-profit organization, pioneered the introduction of antiretroviral medicines to Uganda at the peak of the HIV/AIDS epidemic. MAUL is dedicated to ensuring all patients have access to the highest-quality medicines when they need them, no matter where they live. Since its founding in 1998, MAUL has improved the lives of more than two million patients throughout Uganda by providing diagnostic tests and life-saving medicines. MAUL uses innovative approaches and best practices to purchase and deliver more than 500 medicines that treat HIV/AIDS and other chronic conditions. MAUL maintains state-of-the-art warehouses that ensure drug potency and sufficient inventory to prevent shortages.
For more information, please contact:
Anthony Bugembe, Public Relations & Communications Officer, +256751998957; email@example.com.